Periovance
Pittsburgh, US · Founded 2017 · Delaware corporation
Founders & leadership
JT
Joseph T DonnellyNamed on SEC filing
MF
Michael FareNamed on SEC filing
DS
Dennis SzymaitisNamed on SEC filing
MH
Michael HughesNamed on SEC filing
JN
James NolanNamed on SEC filing
KM
Kenneth MelaniNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$500K disclosed across 1 round · 2019
▶$500KraisedSep 2019 · 6 investors · Other Health CareRule 506(b)
▶$500KraisedSep 2019 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Joseph T DonnellyExecutive Officer, Director
- Michael FareExecutive Officer, Director
- Dennis SzymaitisDirector, Promoter
- Michael HughesDirector
- Velocity Fund Partners LP Velocity Fund Partners, LPPromoter
- James NolanExecutive Officer, Director
- Kenneth MelaniDirector
- Offering amount
- $1.3M
- Amount sold
- $500K
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Periovance raised?
- Periovance has disclosed $500K raised across 1 round.
- Where is Periovance headquartered?
- Periovance is headquartered in Pittsburgh, US.